Attendance at the 2nd to 4th Korea Biochip Society Conference
[Asia Economy Reporter Minji Lee] Cellames announced on the 2nd that it has developed a non-destructive, real-time cell analysis system (CIMS-16) and a cell chip (CIMS-Plate) using transparent electrodes.
To manufacture and sell pharmaceuticals, cosmetics, and chemicals, it is essential to conduct evaluations proving that they are harmless or effective to the human body. Until now, these experiments have been conducted using animal models, but recently, research to replace them with human cells has been actively progressing due to ethical issues.
To replace animal testing, human-derived cells using induced pluripotent stem cells, 3D tissue printing, organoids, and organ chips are used, and a non-destructive and real-time cell analysis system is required to check cell status and drug responses.
The company’s patented transparent electrode-based 8-channel cell chip allows imaging with optical transmittance similar to that of a regular culture dish when observing cells under a microscope. Cellames’ product can simultaneously measure two 8-channel cell chips, enabling 16-channel evaluation, and provides convenient measurement and various analysis results using its self-developed program CIMS-S/W. While overseas companies lead the market, there is no domestic competitor.
The company stated, “We will expand not only to domestic companies requiring cell toxicity evaluation systems but also overseas,” adding, “We are also developing systems necessary for preclinical studies, such as a 96-channel organoid cell analysis and cardiac toxicity evaluation system.”
Meanwhile, the company will attend the Korean Biochip Society from today until the 4th to exhibit the developed products.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
